|
|
|
|
|
Vasogen Announces the Appointments of Dr. Ronald Cresswell and Dr. Calvin Stiller to Board of Directors Toronto, Ontario - January 10, 2006 Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a leader in the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that Ronald M. Cresswell, Ph.D., Hon. D. Sc., F.R.S.E., and Calvin R. Stiller, C.M., O.ONT, M.D., F.R.C.P.(C), have been named to its Board of Directors. Both Dr. Cresswell, former Senior Vice President and Chief Scientific Officer of Warner-Lambert, and Dr. Stiller, co-founder and former Chairman and CEO of the Canadian Medical Discoveries Fund, have considerable experience directing the research, development, and business initiatives of companies commercializing products for the healthcare industry. “Drs. Stiller and Cresswell are highly respected individuals and have outstanding track records in the research and development of new therapeutics for a broad range of healthcare markets,” commented William R. Grant, Chairman of the Board of Vasogen. “I am extremely pleased that both Cal and Ron have agreed to join our Board, as their extensive industry experience will serve Vasogen well as we approach the completion of two pivotal phase III programs targeting large cardiovascular markets." Dr. Ronald Cresswell brings over 30 years of research and commercial development experience in cardiovascular and other important therapeutic areas to Vasogen's Board of Directors. Dr. Cresswell, the former Senior Vice President and Chief Scientific Officer of Warner-Lambert, began his tenure with Warner-Lambert in 1988 as the President of Research and Development of the Parke-Davis Pharmaceutical Research Division. From 1989-1998, he served as Vice President and Chairman of the Parke-Davis Worldwide Pharmaceutical Research Division. Dr. Cresswell’s vision and leadership in the development of Lipitor® at Parke-Davis was instrumental in the product's ultimate success. Dr. Cresswell joined Warner-Lambert from Laporte Industries, Ltd., an international chemical company, where he was Chief Operating Officer. Prior to this, Dr. Cresswell was with Burroughs Wellcome for over twenty years. At Burroughs Wellcome, he held a broad range of research and development positions in both the United Kingdom and the United States, and was responsible for a research staff of over 3,000 people. Dr. Cresswell has served on the Board of Directors of Esperion Therapeutics, Inc., Allergan, Inc., and Curagen Corporation. Dr. Calvin Stiller brings a strong background in medicine and immunology to Vasogen’s Board of Directors and has extensive experience in developing new therapeutics for a broad range of disease targets. He is currently a Professor of Medicine, and a Professor in the Microbiology and Immunology Department at the University of Western Ontario. Dr. Stiller established the Multi-Organ Transplant Service in London, Ontario, and served as the unit’s chief from 1984 to 1996. During this period, he was principal investigator of the Canadian multi-center study that established the importance of cyclosporine in transplantation and led to its worldwide use as first-line therapy for transplant rejection. Dr. Stiller is the co-founder of four healthcare funds including the Canadian Medical Discoveries Fund Inc., where he served as Chairman and Chief Executive Officer. He was a Member of the Council and Executive Committee of the Medical Research Council of Canada (1987-1993) and is currently the Chair of the Ontario Research and Development Challenge Fund and a Board Member of the Ontario Innovation Trust. Dr. Stiller serves on the Board of Directors of NPS Pharmaceuticals, Inc., Spectral Diagnostics Inc., Residence Retirement REIT and CPL Trust and several public endeavors and foundations including, Genome Canada (Chair), MARS (Medical and Related Sciences Discovery District), and OCRN (Ontario Cancer Research Network). He is also the recipient of numerous awards including the MEDEC Award, the Order of Canada, and the Order of Ontario. In May 2002, Dr. Stiller received an Honourary Doctor of Laws Degree from McMaster University in Hamilton. About Vasogen |